वह दृष्टि स्वतंत्रता जिसके आप हकदार हैं

Treat nearsightedness with our EVO ICL (EVO) Implantable Collamer® Lens.

Made From Collamer®, a Collagen Co-Polymer

Proprietary to STAAR Surgical, Collamer® is biocompatible, stable and flexible, enabling minimally invasive insertion and encouraging harmony with your natural eye.

Soft & Pliable

EVO ICL lenses are easy to implant in the eye because of the soft and flexible structure. You won’t even know it’s there other than the fact that you have great vision.

0

उपचार की विस्तृत श्रृंखला

कॉन्टैक्ट लेंस और चश्मा एक परेशानी और सीमित करने वाले हो सकते हैं। ICL -0.5 से लेकर -18 डायोप्टर तक के नुस्खे की एक विस्तृत श्रृंखला का इलाज कर सकता है।

ICL बनाम लेसिक बनाम PRK

जब दृष्टि सुधार की बात आती है, तो यह तय करना मुश्किल हो सकता है कि आपकी आंखों के लिए सबसे अच्छा क्या है। प्रक्रियाओं के बीच अंतर के बारे में जानें और देखें कि क्या ICL आपके लिए सही है।

ICL

लेसिक

PRK

ICL

लेसिक

PRK

तेज और स्पष्ट दृष्टि²

20-30 मिनट की आउटपेशेंट प्रक्रिया

कॉर्नियल ऊतक निकाला नहीं जाता है

"ड्राई आई सिंड्रोम" में योगदान नहीं करता है

ICL

लेसिक

PRK

Removable or Reversible

भविष्य की प्रक्रियाओं के लिए लचीलापन

पतले कॉर्निया का इलाज करता है⁶

यूवी प्रोटेक्शन

दीर्घकालिक इतिहास

इसमें केवल 30 मिनट लगते हैं

ICL प्रक्रिया न्यूनतम इनवेसिव है और लेंस को एक छोटे से चीरे के माध्यम से इम्प्लांट किया जाता है जिससे प्रक्रिया और रिकवरी तेज़ी से होती है। दुनिया भर में लगाए गए 2,000,000 से अधिक लेंसों के साथ, ICL दुनिया भर में कई लोगों के लिए पसंद की तेज़ दृष्टि सुधार प्रक्रिया बन रहा है।

प्रक्रिया के बारे में

वास्तविक जीवन के मरीजों से वास्तविक जीवन की कहानियां

Jennifer Puno 1020x1360
The thing that I love about the Visian ICL is that they are putting a lens in there that can be removed.

Jennifer Puno | Web Designer

Eve Torres 1020x1360
I feel like a big part of health is using what your body already has. Visian ICL is in line with that because it’s keeping your eye completely intact. My eye is still my eye.

Eve Torres Gracie | Jiu Jitsu Instructor

Sara Tso 1020x1360
I would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmer's market.

Sara Tso | Chef

There’s a few big road blocks to having glasses and being a photographer. Now I’ve got EVO and I can run out and live my life unhindered.

Andrew Oxenham | Photographer

I had my first opportunity to put my Visian ICL eyes to the test recently in the Amazon rainforest, and it couldn’t have been more exciting to be able to spot rare species better than ever.

Phil Torres | Entomologist, TV show host

Ready to Discover Visual Freedom With EVO ICL? Find a Doctor Today

Important Safety Information

EVO & EVO TICL is designed for the correction of moderate to high near-sightedness (-0.5 to -20.0 dioptres (D)) and the reduction of near-sightedness in patients with up to -20 dioptres (D) of near-sightedness with less than or equal to 6.0 dioptres (D) of astigmatism. It is indicated for patients who are 21 to 45 years of age. In order to be sure that your surgeon will use a EVO with the most adequate power for your eye, your near-sightedness should be stable for at least a year before undergoing eye surgery. EVO surgery has been documented to safely and effectively correct near-sightedness between -0.5 dioptres (D) to -20.0 dioptres (D) and partially correct near-sightedness up to -20 dioptres in eyes with up to 6.0(D) of astigmatism. If you have near-sightedness within these ranges, EVO surgery may improve your distance vision without eyeglasses or contact lenses. EVO surgery does not eliminate the need for reading glasses, even if you have never worn them before. The EVO represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct myopia such as contact lenses and eye glasses. EVO is not intended to correct any astigmatism you may have. Implantation of the EVO is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care provider. The following represent potential complications/adverse events reported in conjunction with refractive surgery in general: conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, EVO ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO surgery you should have a complete eye examination and talk with your eye care professional about EVO surgery, especially the potential benefits, risks and complications. You should discuss the time needed for healing after surgery.

Important Safety Information

EVO & EVO TICL is designed for the correction of moderate to high near-sightedness (-0.5 to -20.0 dioptres (D)) and the reduction of near-sightedness in patients with up to -20 dioptres (D) of near-sightedness with less than or equal to 6.0 dioptres (D) of astigmatism. It is indicated for patients who are 21 to 45 years of age. In order to be sure that your surgeon will use a EVO with the most adequate power for your eye, your near-sightedness should be stable for at least a year before undergoing eye surgery. EVO surgery has been documented to safely and effectively correct near-sightedness between -0.5 dioptres (D) to -20.0 dioptres (D) and partially correct near-sightedness up to -20 dioptres in eyes with up to 6.0(D) of astigmatism. If you have near-sightedness within these ranges, EVO surgery may improve your distance vision without eyeglasses or contact lenses. EVO surgery does not eliminate the need for reading glasses, even if you have never worn them before. The EVO represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct myopia such as contact lenses and eye glasses. EVO is not intended to correct any astigmatism you may have. Implantation of the EVO is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care provider. The following represent potential complications/adverse events reported in conjunction with refractive surgery in general: conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, EVO ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO surgery you should have a complete eye examination and talk with your eye care professional about EVO surgery, especially the potential benefits, risks and complications. You should discuss the time needed for healing after surgery.

संदर्भ

1Visian ICL Patient Information Booklet

2Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.

3Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5aLee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5bParkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council